Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Cho, K. Park, S. Kim, E. Y. Koyanagi, A. Jacob, L. Yon, D. K. Lee, S. W. Kim, M. S. Radua, J. Elena, D. Il Shin, J. Smith, L.

Immunogenicity of COVID-19 Vaccines in Patients with Diverse Health Conditions: a Comprehensive Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, X. Luo, D. Mei, B. Du, J. Liu, X. Xie, H. Liu, L. Su, S. Mai, G.

Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Chuleerarux, N. Manothummetha, K. Moonla, C. Sanguankeo, A. Kates, O. S. Hirankarn, N. Phongkhun, K. Thanakitcharu, J. Leksuwankun, S. Meejun, T. Thongkam, A. Mongkolkaew, T. Dioverti, M. V. Torvorapanit, P. Langsiri, N. Worasilchai, N. Plongla, R. Chindamporn, A. Gopinath, S. Nissaisorakarn, P. Thaniyavarn, T. Nematollahi, S. Permpalung, N.

Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Yang, X. Zhang, H. Bao, W. Fu, S. Jin, H.

Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tang, K. T. Hsu, B. C. Chen, D. Y.

Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yang, B. Huang, X. Gao, H. Leung, N. H. Tsang, T. K. Cowling, B. J.

Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis

  • Children
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Staadegaard, L. Rönn, M. M. Soni, N. Bellerose, M. E. Bloem, P. Brisson, M. Maheu-Giroux, M. Barnabas, R. V. Drolet, M. Mayaud, P. Dalal, S. Boily, M. C.

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

  • Children
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Sadeghi, Sara Kalantari, Yasamin Shokri, Sima Fallahpour, Morteza Nafissi, Nahid Goodarzi, Azadeh Valizadeh, Rohollah

Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis

  • Children
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Guzman-Holst, A. de Barros, E. Rubio, P. DeAntonio, R. Cintra, O. Abreu, A.

Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020

  • Americas
  • Brazil
  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ SeyedAlinaghi, S. Karimi, A. Mojdeganlou, H. Alilou, S. Mirghaderi, S. P. Noori, T. Shamsabadi, A. Dadras, O. Vahedi, F. Mohammadi, P. Shojaei, A. Mahdiabadi, S. Janfaza, N. Keshavarzpoor Lonbar, A. Mehraeen, E. Sabatier, J. M.

Impact of COVID-19 pandemic on routine vaccination coverage of children and adolescents: A systematic review

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...